Bioequivalence assessment of the two brands of glimepiride tablets

Bioequivalence assessment of the two brands of glimepiride tablets

Background/Aim. Glimepiride, as an antidiabetic from the group of sulfonylurea, is administered perorally in the treatment of diabetes mellitus. The aim of this study was to compare pharmacokinetic profiles and relative bioavailabilities of the two oral formulations of glimepiride, generic and innov...

Full description

Bibliographic Details
Main Authors: Jovanović Dušan, Stojšić Dragan, Zlatković Milica, Jović-Stošić Jasmina, Jovanović Miodrag
Format: Article
Language:English
Published: Military Health Department, Ministry of Defance, Serbia 2006-01-01
Series:Vojnosanitetski Pregled
Subjects:
diabetes mellitus, type 2
drugs, generic
sulfonylurea compounds
therapeutic equivalency
biological availability
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2006/0042-84500612015J.pdf

Internet

http://www.doiserbia.nb.rs/img/doi/0042-8450/2006/0042-84500612015J.pdf

Similar Items